PTCT financials
PTC Therapeutics (PTCT) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
PTCT income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $1.73B | $1.66B | $856.51M | $682.64M | 7.78 |
| 2024 | $806.78M | $749.38M | -$302.57M | -$363.30M | -4.73 |
| 2023 | $937.82M | $872.34M | -$439.50M | -$626.60M | -8.37 |
| 2022 | $698.80M | $654.12M | -$447.41M | -$559.02M | -7.79 |
| 2021 | $538.59M | $506.26M | -$374.44M | -$523.90M | -7.43 |
| 2020 | $380.77M | $361.82M | -$431.77M | -$438.16M | -6.64 |
- PTCT revenue was $1.73B in fiscal 2025, net income $682.64M.
Updated 2026-11-03 00:50 UTC